Alpha Dna Investment Management LLC Gilead Sciences, Inc. Transaction History

Alpha Dna Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$62.32 - $89.47 $1 Million - $1.44 Million	16,083 New	16,083 $0
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $42,842 - $46,811	-675 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $7,980 - $9,105	-133 Reduced 16.46%	675 $43,000
Q4 2020 Mar 24, 2021	SELL	$56.65 - $64.55 $1,076 - $1,226	-19 Reduced 2.3%	808 $47,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $46,849 - $53,382	827 New	827 $48,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.